trending Market Intelligence /marketintelligence/en/news-insights/trending/tbeWhtG3C-d5wr9nWSi7PQ2 content esgSubNav
In This List

Cochlear appoints director

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Cochlear appoints director

Cochlear Ltd. named Bruce Robinson to its board.

Robinson was previously head of the cancer genetics laboratory at the Kolling Institute for Medical Research and is an external director of generic pharmaceutical manufacturer MaynePharma.